Andrew Wakefield, who has linked vaccines to autism, was given a new platform by CBS News now with new claims about the potential dangers from hepatitis B vaccine – based on research on 13 vaccinated monkeys.
The only other source cited was Wakefield’s collaborator and co-author.
Here is how CBS summarized any past controversy:
The study became the centerpiece for an ongoing and nasty fight between vaccine safety advocates who embrace Wakefield’s research and believe vaccines can be administered in a safer fashion, and public health and government officials who attack Wakefield and believe his ideas threaten international vaccination programs.
Notice the framing: vaccine safety advocates “embrace” his research while public health and government officials “attack” it.
Why would CBS not include any independent source to evaluate these claims from research in 13 monkeys? Why would they not mention the allegations from earlier this year that he falsified data in his 1998 study published in The Lancet, widely available online. Excerpt from one story:
10 of the paper’s 13 authors — not including Dr. Wakefield — retracted the paper’s conclusion that the MMR vaccine may cause autism.
Paul Offit, M.D., a pediatrician at Children’s Hospital of Philadelphia, and a prominent critic of Dr. Wakefield, said the new allegations cannot really undermine the credibility of the MMR-autism theory because it had already been disproved.
A series of population-based studies have failed to find evidence that vaccines cause autism.
“I’m not sure what more people need to say than that this man and his theory are discredited,” Dr. Offit said.
He said there was no longer a scientific controversy about the role of vaccines in autism.
At the same time, he said, the Times report is unlikely to change the minds of those who believe in the link.
“There is not one shred of his hypothesis that has held up,” Dr. Offit said.
Opinions on other issues in news, journals, PR, advertising, marketing
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Alan
October 8, 2009 at 12:29 pmDateline NBC also did a story on him just over a month ago.
He’s probably glad most journalists are such easy push overs in the US given his experience in the UK:
http://briandeer.com/mmr-lancet.htm.
Geoff G
October 8, 2009 at 3:41 pmThe fascinating thing about this interview was how he manages to explain that he had no conflict of interest. Although the page you mention – http://briandeer.com/mmr-lancet.htm – has audio of the lawyer saying he PAID FOR Wakefield’s research, the doctor himself says there was no conflict of interest because the money wasn’t spent on the study.
If, for the sake of argument we believe Wakefield and not the lawyer, does this mean that in his view researchers can take money from a vested interest (say, a drug company), shuffle it off somewhere else (say, a golfing vacation), not declare it to a biomedical journal, and to be involved in no conflict of interest?
This man’s stories are just incredible. It’s amazing that he gets away with it.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like